ETON - CIK 0001710340
Eton Pharmaceuticals, Inc. (ETON) reported revenue of $79.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $79.95M | +104.9% |
| FY 2024 | $39.01M | +23.3% |
| FY 2023 | $31.64M | +48.9% |
| FY 2022 | $21.25M | -2.7% |
| FY 2021 | $21.83M | +55879.5% |
| FY 2020 | $39.00K | -95.9% |
| FY 2019 | $959.00K | - |
Eton Pharmaceuticals, Inc. (ETON) reported revenue of $79.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Eton Pharmaceuticals, Inc.'s revenue grew from $959.00K to $79.95M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.